Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the acute kidney injury market?

The market for acute kidney injury has seen significant growth in recent years. A surge is expected from $5.37 billion in 2024 to $5.74 billion in 2025, which represents a compound annual growth rate (CAGR) of 6.9%. The expansion throughout the historical period is attributed to factors such as a rise in chronic diseases, an aging population, an increase in hospital-acquired infections, heightened public awareness of kidney health, and progress in the field of critical care medicine.

What will be the acute kidney injury market size in the future?

Anticipated robust expansion has been predicted for the acute kidney injury market in the ensuing years. The estimations suggest a growth to $7.39 billion by 2029, propelled by a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this projected growth within the forecast period include an increasing incidence of sepsis, a surge in the demand for tailored treatments, escalated government healthcare schemes, augmented healthcare costs in emerging economies, and an enhanced emphasis on personalized medicine as well as regenerative therapies. The forecast period is marked by significant trends such as dialysis devices that are wearable, the use of artificial intelligence in enhancing treatment procedures, portable renal replacement therapy systems, innovations in continuous renal replacement therapy (CRRT), distantly conducted patient monitoring, and the integration of telemedicine.

Get your acute kidney injury market report here!

https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

What main drivers are fueling expansion in the acute kidney injury market?

The surge in diabetes cases is anticipated to fuel the expansion of the acute kidney injury market. Diabetes comprises a set of metabolic diseases identified by elevated blood sugar levels, resulting from the body’s inadequate insulin production or cells’ improper response to insulin. The escalating diabetes prevalence is influenced by aspects like increasing obesity levels, unhealthy eating habits, inactive lifestyles, aging populations, and improved awareness and diagnosis. Acute kidney injury contributes to metabolic and inflammatory modifications potentially affecting insulin resistance and glucose homeostasis, emphasising a complicated interaction that might affect diabetes progression and control. For instance, in March 2024, as per the Office for Health Improvement & Disparities, a UK government department, from March 2022 to March 2023, the proportion of individuals with type 1 diabetes undergoing all eight advised care processes rose by 22%, and for type 2 diabetes, it rose by 21%. Moreover, the percentage reaching the target HbA1c levels went as high as 37.9%, the most substantial figure recorded by the National Diabetes Audit (NDA). Consequently, the rising prevalence of diabetes is advancing the growth of the acute kidney injury market.

What key areas define the segmentation of the global acute kidney injury market?

The acute kidney injury market covered in this report is segmented –

1) By Injury: Pre-Renal Kidney Injury, Post-Renal Kidney Injury, Intrinsic Kidney Injury

2) By Treatment Type: Dialysis, Drug Therapy, Urinary Implants

3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Pre-Renal Kidney Injury: Hypovolemia, Heart Failure-Related Injury, Sepsis-Induced Injury, Renal Artery Stenosis, Hepatorenal Syndrome

2) By Post-Renal Kidney Injury: Ureteral Obstruction, Bladder Outlet Obstruction, Prostate Enlargement (Benign Prostatic Hyperplasia), Kidney Stones, Tumors Affecting Urinary Tract

3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN), Acute Interstitial Nephritis (AIN), Glomerulonephritis, Vasculitis, Rhabdomyolysis-Induced Injury

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

Who are the dominant players expanding their reach in the acute kidney injury market?

Major companies operating in the acute kidney injury market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co. Ltd., Teva Pharmaceutical Industries Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co. Ltd., Quark Pharmaceuticals Inc., Kringle Pharma Inc., Aptabio Therapeutics Inc., Alexion Pharmaceuticals Inc., Alloksys Life Sciences B.V., AM-Pharma B.V., Arch Biopartners Inc., Guard Therapeutics International AB

What are the key trends shaping the future of the acute kidney injury market?

Main players in the acute kidney injury (AKI) market are keenly working towards gaining regulatory approval to improve their product ranges and present innovative treatment solutions. Regulatory authorizations, such as those provided by the FDA or EMA, ensure that a product meets the necessary safety, efficiency, and quality standards before being released on the market. For instance, in December 2023, Mission Therapeutics Ltd., a company based in the UK specializing in biotechnology, secured FDA approval to commence the second phase of clinical trials for their front-line product, MTX652, which is geared towards treating AKI in patients at a high risk after undergoing heart surgery. The prime objective of MTX652 is to target essential pathways involved in kidney damage and healing processes, with a goal to minimize inflammation, avert additional kidney harm, and encourage recuperation. What sets this trial apart is its emphasis on employing innovative therapeutic strategies to tackle the root molecular reasons behind AKI, potentially offering more efficient treatment alternatives compared to current ones. The second phase trial will assess MTX652’s safety, effectiveness, and pharmacokinetics, providing vital data that could pave the way for wider clinical application and potential authorization.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21079

Which regions are emerging as leaders in the acute kidney injury market?

North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Influenza Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Medical And Diagnostic Laboratory Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Bleeding Disorder Testing Global Market Report 2025

https://thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: